Endothelin a receptor antagonism enhances inhibitory effects of anti-ganglioside GD2 monoclonal antibody on invasiveness and viability of human osteosarcoma cells

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Liu, Bo ^a   Wu, Yi ^b   Zhou, Yu ^a   Peng, Dan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Provincial Meteorological Bureau   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); GELATINASE A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 14G2A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; AMINOPYRIDINE DERIVATIVE; ENDOTHELIN A RECEPTOR ANTAGONIST; GANGLIOSIDE; GANGLIOSIDE, GD2; MORPHOLINE DERIVATIVE; NVP-BKM120;

ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CELL INVASION; CELL VIABILITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOTHERAPY; OSTEOSARCOMA; PROTEIN EXPRESSION; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; NEOPLASM INVASIVENESS; TUMOR CELL LINE;

AMINOPYRIDINES; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL SURVIVAL; ENDOTHELIN A RECEPTOR ANTAGONISTS; GANGLIOSIDES; HUMANS; MORPHOLINES; NEOPLASM INVASIVENESS; OSTEOSARCOMA; PHOSPHATIDYLINOSITOL 3-KINASES;

EID: 84899627450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093576     Document Type: Article

References (29)

1. Ottaviani G, Jaffe N (2010) The epidemiology of osteosarcoma. Cancer Treat Res 152: 3-13.
2. Gorlick R, Anderson P, Andrulis I (2003) Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin. Cancer Res 9: 5442-5453.
3. Wittig JC, Bickels J, Priebat D (2002) Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 65: 1123-1132.
4. Todeschini AR, Hakomori SI (2008) Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim Biophys Acta 1780: 421-433.
5. Ruf P, Schä fer B, Eissler N, Mocikat R, Hess J, et al. (2012) Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model. J Transl Med 10: 219.
6. Navid F, Santana VM, Barfield RC (2010) Anti-GD2 antibody therapy for GD2-expressing tumors. Curr Cancer Drug Targets 10: 200-209.
7. Horwacik I, Durbas M, Boratyn E, We?grzyn P, Rokita H (2013) Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells. Cancer Lett 341: 248-264.
8. Cochonneau D, Terme M, Michaud A, Dorvillius M, Gautier N, et al. (2013) Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo. Cancer Lett 333: 194-204.
9. Roth M, Linkowski M, Tarim J, Piperdi S, Sowers R, et al. (2013) Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma. Cancer doi: 10.1002/cncr.28461 [Epub ahead of print].
10. Zhao Y, Liao Q, Zhu Y, Long H (2011) Endothelin-1 promotes osteosarcoma cell invasion and survival against cisplatin-induced apoptosis. Clin Orthop Relat Res 469: 3190-3199.
11. Felx M, Guyot MC, Isler M, Turcotte RE, Doyon J, et al. (2006) Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin Sci (Lond) 110: 645-654.
12. Li Y, Liao Q, Li K, Zhong D, Weng X, et al. (2012) Knockdown of endothelin A receptor expression inhibits osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse model. Mol Med Rep 5: 1391-1395.
13. Li B, Yang Y, Jiang S, Ni B, Chen K, et al. (2012) Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway. Int J Oncol 41: 1809-1819.
14. Liu ZL, Mao JH, Peng AF, Yin QS, Zhou Y, et al. (2013) Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro. Mol Med Rep 7: 608-612.
15. Zhao G, Cai C, Yang T, Qiu X, Liao B, et al. (2013) MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 8: e53906.
16. Wang TF, Wang H, Peng AF, Luo QF, Liu ZL, et al. (2013) Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro. Biochem Biophys Res Commun 440: 229-234.
17. Sun P, Xiong H, Kim TH, Ren B, Zhang Z (2006) Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells. Mol Pharmacol 69: 520-531.
18. Cazet A, Bobowski M, Rombouts Y, Lefebvre J, Steenackers A, et al. (2012) The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase. Glycobiology 22: 806-816.
19. Wang B, Feng P, Xiao Z, Ren EC (2009) LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma. J Hepatol. 50:528-537.
20. Feng Y, Hu J, Ma J, Feng K, Zhang X, et al. (2011) RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Eur J Cancer 47:2353-2363.
21. Jo YK, Park SJ, Shin JH, Kim Y, Hwang JJ, et al. (2011) ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells. Biochem Biophys Res Commun 404:1039-1043.
22. Qazi H, Shi ZD, Tarbell JM (2011) Fluid shear stress regulates the invasive potential of glioma cells via modulation of migratory activity and matrix metalloproteinase expression. PLoS One 6:e20348.
23. Cao CM, Zhang Y, Weisleder N, Ferrante C, Wang X, et al. (2010) MG53 constitutes a primary determinant of cardiac ischemic preconditioning. Circulation 121:2565-2574.
24. Fos C, Salles A, Lang V, Carrette F, Audebert S, et al. (2008) ICOS ligation recruits the p50alpha PI3K regulatory subunit to the immunological synapse. J Immunol 181:1969-1977.
25. Zheng Y, Yang J, Qian J, Zhang L, Lu Y, et al. (2012) Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone. J Mol Med (Berl) 90: 695-706.
26. Nelson J, Bagnato A, Battistini B, Nisen P (2003) The endothelin axis: emerging role in cancer. Nat Rev Cancer 3: 110-116.
27. Ahmed M, Modak S, Sequeira S (2013) Acute Pain Relief After Mantram Meditation in Children With Neuroblastoma Undergoing Anti-GD2 Monoclonal Antibody Therapy. J Pediatr Hematol Oncol [Epub ahead of print].
28. Qin J, Tang J, Jiao L, Ji J, Chen WD, et al. (2013) A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin b1/FAK/PI3K/AKT/b-catenin signaling. Life Sci 93: 655-663.
29. Song NR, Chung MY, Kang NJ, Seo SG, Jang TS, et al. (2014) Quercetin suppresses invasion and migration of H-Ras-transformed MCF10A human epithelial cells by inhibiting phosphatidylinositol 3-kinase. Food Chem 142: 66-71.